New Delhi, February 9 GlaxoSmithKline Pharmaceuticals announced on Monday a 29 per cent increase in consolidated profit after tax to Rs 296 crore for the third quarter ended December 31, 2025.
The pharmaceutical company reported a profit after tax of Rs 230 crore for the October-December period of the previous fiscal year.
Revenue from operations rose to Rs 1,041 crore from Rs 949 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals Ltd said in a regulatory filing.
The company stated that its strong performance is due to the overall economic environment and efforts to address internal supply chain challenges.
The implementation of the new labor codes had minimal impact on the company, it added.
Shares of the company closed 1.01 per cent higher at Rs 2,511 apiece on the BSE.